These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27230623)

  • 21. Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study.
    Ahmed FZ; Fullwood C; Zaman M; Qamruddin A; Cunnington C; Mamas MA; Sandoe J; Motwani M; Zaidi A
    PLoS One; 2019; 14(1):e0206611. PubMed ID: 30601808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclavian and Axillary Vein Access Versus Cephalic Vein Cutdown for Cardiac Implantable Electronic Device Implantation: A Meta-Analysis.
    Atti V; Turagam MK; Garg J; Koerber S; Angirekula A; Gopinathannair R; Natale A; Lakkireddy D
    JACC Clin Electrophysiol; 2020 Jun; 6(6):661-671. PubMed ID: 32553216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The predictors and economic burden of early-, mid- and late-onset cardiac implantable electronic device infections: a retrospective cohort study in Ontario, Canada.
    Daneman N; Homenauth E; Saskin R; Ng R; Ha A; Wijeysundera HC
    Clin Microbiol Infect; 2020 Feb; 26(2):255.e1-255.e6. PubMed ID: 30797886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfemoral access when superior venous approach is not feasible equals overall success of permanent pacemaker implantation. Ten-year series.
    García Guerrero JJ; Fernández de la Concha Castañeda J; Doblado Calatrava M; Redondo Méndez Á; Lázaro Medrano M; Merchán Herrera A
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):638-643. PubMed ID: 28349586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous Obstruction in Asymptomatic Patients Undergoing First Implantation or Revision of a Cardiac Pacemaker or Implantable Cardioverter-Defibrillator: A Retrospective Single Center Analysis.
    Pieper CC; Weis V; Fimmers R; Rajab I; Linhart M; Schild HH; Nähle CP
    Rofo; 2015 Nov; 187(11):1029-35. PubMed ID: 26200569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardiac device procedures in older patients: use and in-hospital outcomes.
    Swindle JP; Rich MW; McCann P; Burroughs TE; Hauptman PJ
    Arch Intern Med; 2010 Apr; 170(7):631-7. PubMed ID: 20386008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axillary vein access for permanent pacemaker and implantable cardioverter defibrillator implantation: Fluoroscopy compared to ultrasound.
    Migliore F; Fais L; Vio R; De Lazzari M; Zorzi A; Bertaglia E; Iliceto S
    Pacing Clin Electrophysiol; 2020 Jun; 43(6):566-572. PubMed ID: 32394452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation.
    Mittal S; Piccini JP; Snell J; Prillinger JB; Dalal N; Varma N
    J Interv Card Electrophysiol; 2016 Aug; 46(2):129-36. PubMed ID: 26860839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UltraSound Axillary Vein Access (USAA): Learning curve and randomized comparison to traditional venous access for cardiac device implantation.
    Courtney AM; Chandler JK; Anderson J; Shrestha A; Noheria A; Pimentel R; Dendi R; Ramirez R; Reddy YM; Sheldon SH
    Pacing Clin Electrophysiol; 2022 Dec; 45(12):1364-1371. PubMed ID: 36270271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous subclavian venous occlusion before electronic device implantation.
    Kodani T; Mine T; Kishima H; Ashida K; Masuyama T
    Asian Cardiovasc Thorac Ann; 2015 Jun; 23(5):530-4. PubMed ID: 25614481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusual Venous Access for Device Implantation.
    Al-Sadawi M; Budzikowski AS
    Am J Case Rep; 2019 Oct; 20():1482-1486. PubMed ID: 31591374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a systematic review and meta-analysis.
    Benz AP; Vamos M; Erath JW; Hohnloser SH
    Europace; 2019 Jan; 21(1):121-129. PubMed ID: 30020452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs and complications associated with transvenous lead reoperation in cardiac implantable electronic devices.
    Griffiths RI; Amorosi SL; Jacobsen CM; McBee PJ; Menzin J; Reynolds MR
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):503-511. PubMed ID: 31916328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axillary vein technique for pacemaker and implantable defibrillator leads implantation: a safe and alternative approach?
    Migliore F; Curnis A; Bertaglia E
    J Cardiovasc Med (Hagerstown); 2016 Apr; 17(4):309-13. PubMed ID: 25252042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade.
    Haghjoo M; Nikoo MH; Fazelifar AF; Alizadeh A; Emkanjoo Z; Sadr-Ameli MA
    Europace; 2007 May; 9(5):328-32. PubMed ID: 17369270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac implantable electronic device infection in patients with end-stage renal disease.
    Guha A; Maddox WR; Colombo R; Nahman NS; Kintziger KW; Waller JL; Diamond M; Murphy M; Kheda M; Litwin SE; Sorrentino RA
    Heart Rhythm; 2015 Dec; 12(12):2395-401. PubMed ID: 26253036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights.
    Voigt A; Shalaby A; Saba S
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):414-9. PubMed ID: 19793359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac device complications in the cognitively impaired.
    Jama A; Rabinstein A; Hodge D; Herges R; Asirvatham S; Cha YM; Powell B; Rea RF; Friedman P
    Pacing Clin Electrophysiol; 2013 Sep; 36(9):1061-7. PubMed ID: 23822919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.